Black Rock Inc. Petros Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.68 - $1.49 $18,101 - $39,663	-26,620 Reduced 13.89%	165,095 $139,000
Q1 2022 May 12, 2022	BUY	$1.07 - $3.36 $184,206 - $578,444	172,156 Added 880.19%	191,715 $300,000
Q4 2021 Feb 10, 2022	BUY	$1.33 - $4.09 $1,246 - $3,832	937 Added 5.03%	19,559 $65,000
Q3 2021 Nov 09, 2021	SELL	$1.82 - $3.2 $575 - $1,011	-316 Reduced 1.67%	18,622 $38,000
Q2 2021 Aug 11, 2021	BUY	$2.87 - $4.11 $54,352 - $77,835	18,938 New	18,938 $59,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $6.42M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.